The European AIDS Treatment Group (EATG), February 2023 For the first time in humans, a research team has shown that, as early as the first days of infection, HIV is able to create reservoirs where it will hide and persist during antiretroviral therapy. Until now, the scientific community did not know exactly when or how these viral reservoirs—the existence of which is a major obstacle to curing...
Support for ending and managing HIV
Australian Government Department of Health, 29 November 2018 The Australian Government is strengthening its commitment to ending HIV with the announcement of funding for a new strategy that aims to virtually eliminate the transmission of HIV, the approval of the first HIV self-testing kit and the listing of a new medicine on the PBS. The first HIV self-testing kit, the Atomo Self Test was...
How HIV Possibly Jumped From Monkey To Man
Asian Scientist, April 12, 2018
Scientists in Japan have discovered a protein that may have enabled the simian immunodeficiency virus (SIV) to be transmitted to humans. Their findings are published in Cell Host & Microbe. The human immunodeficiency virus (HIV) is believed to have evolved from a SIV that originated in chimpanzees.
Read more of How HIV Possibly Jumped From Monkey To Man
HIV vaccine therapy lets five people control virus without drugs
New Scientist, 22 February 2017
FIVE people with HIV are currently free of detectable virus – and daily drugs – thanks to a new vaccine-based therapy.
Although it is early days, one participant has been drug-free for seven months.
Read more here
Small risk of sexual transmission of HIV persists through first six months of ART
nam/aidsmap, 10 May 2016 A risk of HIV transmission to sexual partners persists for six months after the initiation of antiretroviral therapy, investigators from a large prospective prevention study confirm in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Over 1,500 serodiscordant heterosexual couples were included in the analysis. Initiation of antiretroviral therapy...
Even in undetectable patients, HIV is still replicating in the lymphoid tissues
Slate, January 27 2016 While progress toward a vaccine and even a functional cure for HIV has accelerated in recent years, a major obstacle has been the “viral reservoir”—locations and cell types in a body where the virus can persist at very low levels even when treatment has succeeded at making it undetectable in the blood by standard testing. Published in the Jan. 27 issue of Nature, a new...